Geode Capital Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.35B Sell
2,562,886
-98,113
-4% -$55M 0.07% 237
2026
Q1
$1.5B Buy
2,660,999
+77,060
+3% +$49.4M 0.09% 191
2025
Q4
$1.75B Buy
2,583,939
+86,263
+3% +$58.7M 0.11% 148
2025
Q3
$1.59B Buy
2,497,676
+33,386
+1% +$20.3M 0.1% 163
2025
Q2
$1.32B Buy
2,464,290
+54,402
+2% +$26M 0.09% 184
2025
Q1
$1.01B Buy
2,409,888
+112,617
+5% +$48.9M 0.08% 232
2024
Q4
$948M Buy
2,297,271
+37,734
+2% +$16.6M 0.07% 236
2024
Q3
$1.14B Buy
2,259,537
+40,349
+2% +$19.6M 0.09% 193
2024
Q2
$1.08B Buy
2,219,188
+62,895
+3% +$31.6M 0.09% 180
2024
Q1
$1.16B Buy
2,156,293
+52,035
+2% +$28.4M 0.11% 168
2023
Q4
$1.17B Buy
2,104,258
+40,119
+2% +$18.8M 0.12% 147
2023
Q3
$901M Buy
2,064,139
+51,140
+3% +$25.5M 0.11% 170
2023
Q2
$1.01B Buy
2,012,999
+66,660
+3% +$31.9M 0.12% 146
2023
Q1
$972M Buy
1,946,339
+26,197
+1% +$12.5M 0.13% 141
2022
Q4
$782M Buy
1,920,142
+28,791
+2% +$11.2M 0.11% 183
2022
Q3
$616M Buy
1,891,351
+28,510
+2% +$10.5M 0.09% 213
2022
Q2
$652M Buy
1,862,841
+14,960
+0.8% +$6.1M 0.1% 203
2022
Q1
$1.01B Buy
1,847,881
+48,360
+3% +$25.4M 0.13% 141
2021
Q4
$1.18B Buy
1,799,521
+31,403
+2% +$19.7M 0.14% 122
2021
Q3
$1.1B Buy
1,768,118
+56,661
+3% +$38.1M 0.15% 115
2021
Q2
$1.08B Buy
1,711,457
+84,946
+5% +$46.9M 0.15% 118
2021
Q1
$794M Buy
1,626,511
+47,752
+3% +$23.9M 0.12% 146
2020
Q4
$787M Buy
1,578,759
+13,443
+0.9% +$6.01M 0.13% 134
2020
Q3
$614M Buy
1,565,316
+174,712
+13% +$64.6M 0.12% 148
2020
Q2
$459M Sell
1,390,604
-187,203
-12% -$54.2M 0.1% 184
2020
Q1
$382M Buy
1,577,807
+26,141
+2% +$6.82M 0.1% 182
2019
Q4
$405M Buy
1,551,666
+48,968
+3% +$12.9M 0.08% 239
2019
Q3
$408M Buy
1,502,698
+60,996
+4% +$17M 0.1% 215
2019
Q2
$396M Buy
1,441,702
+64,037
+5% +$15.8M 0.1% 208
2019
Q1
$308M Buy
1,377,665
+214,756
+18% +$44.3M 0.08% 248
2018
Q4
$216M Buy
1,162,909
+81,641
+8% +$16.7M 0.07% 280
2018
Q3
$269M Buy
1,081,268
+55,386
+5% +$13.4M 0.08% 255
2018
Q2
$223M Buy
1,025,882
+30,639
+3% +$6.31M 0.07% 278
2018
Q1
$190M Buy
995,243
+40,659
+4% +$7.5M 0.06% 305
2017
Q4
$149M Buy
954,584
+16,313
+2% +$2.57M 0.05% 363
2017
Q3
$146M Buy
938,271
+24,029
+3% +$3.8M 0.05% 336
2017
Q2
$147M Sell
914,242
-7,037
-0.8% -$1.14M 0.06% 325
2017
Q1
$142M Buy
921,279
+270,871
+42% +$37.3M 0.06% 324
2016
Q4
$76.2M Buy
650,408
+39,704
+7% +$4.53M 0.04% 469
2016
Q3
$68.8M Buy
610,704
+19,978
+3% +$2.11M 0.03% 472
2016
Q2
$54.8M Buy
590,726
+14,395
+2% +$1.24M 0.03% 512
2016
Q1
$45.1M Buy
576,331
+22,351
+4% +$1.61M 0.02% 566
2015
Q4
$40.4M Sell
553,980
-4,620
-0.8% -$330K 0.02% 588
2015
Q3
$41.5M Buy
558,600
+8,921
+2% +$639K 0.03% 563
2015
Q2
$35.3M Sell
549,679
-18,911
-3% -$1.31M 0.02% 643
2015
Q1
$43.9M Buy
568,590
+16,682
+3% +$1.3M 0.03% 561
2014
Q4
$40.9M Sell
551,908
-15,708
-3% -$1.1M 0.02% 554
2014
Q3
$33.4M Buy
567,616
+1,832
+0.3% +$116K 0.02% 605
2014
Q2
$37.8M Buy
565,784
+39,700
+8% +$2.52M 0.02% 563
2014
Q1
$31.9M Buy
526,084
+35,376
+7% +$2.11M 0.02% 610
2013
Q4
$26.1M Buy
490,708
+45,526
+10% +$2.4M 0.02% 658
2013
Q3
$22.2M Sell
445,182
-5,032
-1% -$242K 0.02% 648
2013
Q2
$20.2M Buy
+450,214
New +$19.7M 0.02% 634

Other funds holding IDXX

Geode Capital Management's IDXX Position: Q2 2026 in Review

Geode Capital Management reduced its Idexx Laboratories (IDXX) stake by 3.7% in Q2 2026, selling an estimated $55M and leaving 2,562,886 shares worth $1.35B. The position accounts for 0.07% of the portfolio, ranked #237.

Geode Capital Management first reported a position in IDXX in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.75B in Q4 2025. 1,300 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Geode Capital Management held 2,562,886 shares of Idexx Laboratories worth $1.35B as of Q2 2026.
  • Geode Capital Management sold 98,113 Idexx Laboratories shares in Q2 2026, an estimated $55M.
  • Idexx Laboratories made up 0.07% of Geode Capital Management's portfolio in Q2 2026, its #237 holding.
  • Geode Capital Management first reported a position in Idexx Laboratories in Q2 2013 and has held it in 53 quarters since.
  • Geode Capital Management's Idexx Laboratories position peaked at $1.75B in Q4 2025.
  • 1,300 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.